Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews · Headline outcomes only

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 20%High 4 · 80%

Etanercept (25 mg) + DMARD · participants with rheumatoid arthritis

The intervention leads to higher etanercept (25 mg) + DMARD (high certainty).

1 finding from 1 review

Etanercept for the treatment of rheumatoid arthritis 2013 · Cochrane Headline outcomes only
RR 1.52 [1.36, 1.7]
2 studies · 958 participants
High

Etanercept + DMARD vs. DMARD · participants with rheumatoid arthritis

The intervention leads to higher etanercept + DMARD vs. DMARD (high certainty).

1 finding from 1 review

Etanercept for the treatment of rheumatoid arthritis 2013 · Cochrane Headline outcomes only
RR 2.82 [1.71, 4.68]
5 studies · 1118 participants
High

Etanercept vs. DMARD · participants with rheumatoid arthritis

The intervention leads to higher etanercept vs. DMARD (high certainty).

1 finding from 1 review

Etanercept for the treatment of rheumatoid arthritis 2013 · Cochrane Headline outcomes only
RR 1.17 [1.02, 1.35]
3 studies · 1112 participants
High

Etanercept (25 mg) + DMARD · participants with rheumatoid arthritis

1 finding from 1 review

Etanercept for the treatment of rheumatoid arthritis 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 894 participants
High

Etanercept + DMARD vs. Etanercept · participants with rheumatoid arthritis

The intervention probably leads to higher etanercept + DMARD vs. Etanercept (moderate certainty).

1 finding from 1 review

Etanercept for the treatment of rheumatoid arthritis 2013 · Cochrane Headline outcomes only
RR 1.44 [1.16, 1.79]
3 studies · 805 participants
Moderate